{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:43:34Z","timestamp":1790520214767,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000276","name":"Department of Health","doi-asserted-by":"publisher","award":["DOH-101-TD-B-111-001"],"award-info":[{"award-number":["DOH-101-TD-B-111-001"]}],"id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health","doi-asserted-by":"publisher","award":["DOH-102-TD-B-111-001"],"award-info":[{"award-number":["DOH-102-TD-B-111-001"]}],"id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["NSC-101-2314-B-002-141"],"award-info":[{"award-number":["NSC-101-2314-B-002-141"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["NSC-102-2314-B-002-120"],"award-info":[{"award-number":["NSC-102-2314-B-002-120"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["100CAP1020-2"],"award-info":[{"award-number":["100CAP1020-2"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.clcc.2015.02.003","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T21:02:25Z","timestamp":1424466145000},"page":"177-184.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7334-1912","authenticated-orcid":false,"given":"Yu-Yun","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Huei","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu-Lin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Zhe","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Lii","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Shu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2015.02.003_bib1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2015.02.003_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2015.02.003_bib3","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.clcc.2015.02.003_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.7716512","article-title":"Protein lipidation in cell signaling","volume":"268","author":"Casey","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.clcc.2015.02.003_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.clcc.2015.02.003_bib6","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2174\/092986712804143349","article-title":"Obesity-driven inflammation and colorectal cancer","volume":"19","author":"Vazzana","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.clcc.2015.02.003_bib7","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/ijc.27942","article-title":"Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers","volume":"132","author":"Toriola","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2015.02.003_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/156800911795538066","article-title":"Cytokines, inflammation and colon cancer","volume":"11","author":"Klampfer","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.clcc.2015.02.003_bib9","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","article-title":"Inflammation and colon cancer","volume":"138","author":"Terzic","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clcc.2015.02.003_bib10","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2015.02.003_bib11","first-page":"4756","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients","volume":"9","author":"Higuchi","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2015.02.003_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jjco\/hyq010","article-title":"Analysis of the effect of serum interleukin-6 (IL-6) and soluble IL-6 receptor levels on survival of patients with colorectal cancer","volume":"40","author":"Yeh","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clcc.2015.02.003_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00384-009-0818-8","article-title":"Serum interleukin-6 levels in colorectal cancer patients\u2013a summary of published results","volume":"25","author":"Knupfer","year":"2010","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.clcc.2015.02.003_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2010.09.011","article-title":"Liposomal pravastatin inhibits tumor\u00a0growth by targeting cancer-related inflammation","volume":"148","author":"Coimbra","year":"2010","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.clcc.2015.02.003_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/HCO.0b013e3283398e53","article-title":"Statins and inflammation: an update","volume":"25","author":"Quist-Paulsen","year":"2010","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.clcc.2015.02.003_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02693938","article-title":"Statins and biomarkers of inflammation","volume":"9","author":"Devaraj","year":"2007","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.clcc.2015.02.003_bib17","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2015.02.003_bib18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jjco\/hyq057","article-title":"Cancer trends in Taiwan","volume":"40","author":"Chiang","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clcc.2015.02.003_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.lungcan.2006.11.009","article-title":"Recurrent responses to non\u2013small-cell lung cancer brain metastases with erlotinib","volume":"56","author":"Popat","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clcc.2015.02.003_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14740330903460317","article-title":"Platelet count less than SHARP: what does a case series reveal?","volume":"9","author":"Saif","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clcc.2015.02.003_bib21","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC Classification Index With DDDs, 2013, World Health Organization; Oslo, Norway, 2012."},{"key":"10.1016\/j.clcc.2015.02.003_bib22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clcc.2015.02.003_bib23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.clcc.2015.02.003_bib24","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s10620-009-0790-8","article-title":"For patients with colorectal cancer, the long-term use of statins is associated with better\u00a0clinical outcomes","volume":"54","author":"Siddiqui","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clcc.2015.02.003_bib25","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/jnci\/djr307","article-title":"Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803","volume":"103","author":"Ng","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2015.02.003_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/1471-2407-12-487","article-title":"Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage","volume":"12","author":"Lakha","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2015.02.003_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/aje\/kwm070","article-title":"Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect","volume":"166","author":"Brookhart","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clcc.2015.02.003_bib28","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/DCR.0b013e3182a4b236","article-title":"Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer","volume":"56","author":"Mace","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2015.02.003_bib29","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1158\/1078-0432.CCR-07-0366","article-title":"Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer","volume":"13","author":"Malesci","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2015.02.003_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM200001133420201","article-title":"Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer","volume":"342","author":"Gryfe","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2015.02.003_bib31","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1200\/JCO.2010.30.1366","article-title":"Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer","volume":"29","author":"Hutchins","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2015.02.003_bib32","unstructured":"Clinicaltrials.gov [Web site]. Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery. Available at: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01011478. Accessed: July 24,\u00a02014."}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002815000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002815000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:02:34Z","timestamp":1761519754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002815000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1533002815000328"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2015.02.003","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2015.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}